keyword
https://read.qxmd.com/read/38580646/translation-velocity-determines-the-efficacy-of-engineered-suppressor-trnas-on-pathogenic-nonsense-mutations
#21
JOURNAL ARTICLE
Nikhil Bharti, Leonardo Santos, Marcos Davyt, Stine Behrmann, Marie Eichholtz, Alejandro Jimenez-Sanchez, Jeong S Hong, Andras Rab, Eric J Sorscher, Suki Albers, Zoya Ignatova
Nonsense mutations - the underlying cause of approximately 11% of all genetic diseases - prematurely terminate protein synthesis by mutating a sense codon to a premature stop or termination codon (PTC). An emerging therapeutic strategy to suppress nonsense defects is to engineer sense-codon decoding tRNAs to readthrough and restore translation at PTCs. However, the readthrough efficiency of the engineered suppressor tRNAs (sup-tRNAs) largely varies in a tissue- and sequence context-dependent manner and has not yet yielded optimal clinical efficacy for many nonsense mutations...
April 5, 2024: Nature Communications
https://read.qxmd.com/read/38572748/fine-tuning-the-trna-anticodon-arm-for-multiple-consecutive-incorporations-of-%C3%AE-amino-acids-and-analogs
#22
JOURNAL ARTICLE
Takayuki Katoh, Hiroaki Suga
Ribosomal incorporation of β-amino acids into nascent peptides is much less efficient than that of the canonical α-amino acids. To overcome this, we have engineered a tRNA chimera bearing T-stem of tRNAGlu and D-arm of tRNAPro1, referred to as tRNAPro1E2, which efficiently recruits EF-Tu and EF-P. Using tRNAPro1E2 indeed improved β-amino acid incorporation. However, multiple/consecutive incorporations of β-amino acids are still detrimentally poor. Here, we attempted fine-tuning of the anticodon arm of tRNAPro1E2 aiming at further enhancement of β-amino acid incorporation...
April 4, 2024: Nucleic Acids Research
https://read.qxmd.com/read/38570452/crystallographic-studies-of-kras-in-complex-with-small-molecules-and-ras-binding-proteins
#23
JOURNAL ARTICLE
Albert H Chan, Dhirendra K Simanshu
RAS proteins play a vital role in regulating downstream signaling and essential cellular processes, positioning them as key players in normal cellular physiology and disease development. Among the various isoforms of RAS, KRAS stands out as one of the most frequently mutated genes in human cancer. The prevalence of RAS mutations in cancer often involves single amino acid substitutions at codons 12, 13, or 61. These mutations disrupt the RAS protein's inherent ability to transition between its active and inactive states, resulting in a constant activation signal and driving uncontrolled cell growth...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38563763/a-measles-vectored-vaccine-candidate-expressing-prefusion-stabilized-sars-cov-2-spike-protein-brought-to-phase-i-ii-clinical-trials-candidate-selection-in-a-preclinical-murine-model
#24
JOURNAL ARTICLE
Jérémy Brunet, Zaineb Choucha, Marion Gransagne, Houda Tabbal, Min-Wen Ku, Julian Buchrieser, Priyanka Fernandes, Damien Batalie, Jodie Lopez, Laurence Ma, Evelyne Dufour, Emeline Simon, David Hardy, Stéphane Petres, Françoise Guinet, Helene Strick-Marchand, Marc Monot, Pierre Charneau, Laleh Majlessi, W Paul Duprex, Christiane Gerke, Annette Martin, Nicolas Escriou
In the early COVID-19 pandemic with urgent need for countermeasures, we aimed at developing a replicating viral vaccine using the highly efficacious measles vaccine as vector, a promising technology with prior clinical proof of concept. Building on our successful pre-clinical development of a measles virus (MV)-based vaccine candidate against the related SARS-CoV, we evaluated several recombinant MV expressing codon-optimized SARS-CoV-2 spike glycoprotein. Candidate V591 expressing a prefusion-stabilized spike through introduction of two proline residues in HR1 hinge loop, together with deleted S1/S2 furin cleavage site and additional inactivation of the endoplasmic reticulum retrieval signal, was the most potent in eliciting neutralizing antibodies in mice...
April 2, 2024: Journal of Virology
https://read.qxmd.com/read/38555573/development-of-membrane-protein-based-vaccine-against-lumpy-skin-disease-virus-lsdv-using-immunoinformatic-tools
#25
JOURNAL ARTICLE
Md Salauddin, Mohammad Enamul Hoque Kayesh, Md Suruj Ahammed, Sukumar Saha, Md Golzar Hossain
INTRODUCTION: Lumpy skin disease, an economically significant bovine illness, is now found in previously unheard-of geographic regions. Vaccination is one of the most important ways to stop its further spread. AIM: Therefore, in this study, we applied advanced immunoinformatics approaches to design and develop an effective lumpy skin disease virus (LSDV) vaccine. METHODS: The membrane glycoprotein was selected for prediction of the different B- and T-cell epitopes by using the immune epitope database...
May 2024: Veterinary Medicine and Science
https://read.qxmd.com/read/38542528/quantitative-shotgun-proteomic-analysis-of-bacteria-after-overexpression-of-recombinant-spider-miniature-spidroin-masp1
#26
JOURNAL ARTICLE
Kathryn Randene, J Alexander Hoang Mendoza, Michael Ysit, Craig Vierra
Spider silk has extraordinary mechanical properties, displaying high tensile strength, elasticity, and toughness. Given the high performance of natural fibers, one of the long-term goals of the silk community is to manufacture large-scale synthetic spider silk. This process requires vast quantities of recombinant proteins for wet-spinning applications. Attempts to synthesize large amounts of native size recombinant spidroins in diverse cell types have been unsuccessful. In these studies, we design and express recombinant miniature black widow MaSp1 spidroins in bacteria that incorporate the N-terminal and C-terminal domain (NTD and CTD), along with varying numbers of codon-optimized internal block repeats...
March 21, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38540259/the-production-of-complement-inhibitor-proteins-in-mammalian-cell-lines-light-at-the-end-of-the-tunnel
#27
REVIEW
Attila Szvetnik, Vilmos Tubak
Therapeutic recombinant proteins are powerful tools used for the treatment of many detrimental diseases such as diabetes, cancer, multiple sclerosis, rheumatoid arthritis, hepatitis, and many more. Their importance in disease therapy is growing over small molecule drugs because of their advantages like specificity and reduced side effects. However, the large-scale production of certain recombinant proteins is still challenging despite impressive advancements in biomanufacturing. The complement cascade is considered a rich source of drug targets and natural regulator proteins with great therapeutic potential...
March 14, 2024: Biomedicines
https://read.qxmd.com/read/38538674/in-silico-designed-novel-multi-epitope-mrna-vaccines-against-brucella-by-targeting-extracellular-protein-btub-and-lptd
#28
JOURNAL ARTICLE
Juan Shi, Yuejie Zhu, Zhengwei Yin, Yueyue He, Yujiao Li, Gulishati Haimiti, Xinru Xie, Ce Niu, Wenhong Guo, Fengbo Zhang
Brucella, a gram-negative intracellular bacterium, causing Brucellosis, a zoonotic disease with a range of clinical manifestations, from asymptomatic to fever, fatigue, loss of appetite, joint and muscle pain, and back pain, severe patients have developed serious diseases affecting various organs. The mRNA vaccine is an innovative type of vaccine that is anticipated to supplant traditional vaccines. It is widely utilized for preventing viral infections and for tumor immunotherapy. However, research regarding its effectiveness in preventing bacterial infections is limited...
March 27, 2024: Scientific Reports
https://read.qxmd.com/read/38522573/strategy-for-the-optimization-of-read-through-therapy-for-junctional-epidermolysis-bullosa-with-col17a1-nonsense-mutation
#29
JOURNAL ARTICLE
Saliha Beyza Sayar, Cristina Has
The read-through therapy suppresses premature termination codons and induces read-through activity consequently restoring missing proteins. Aminoglycosides are widely studied as read-through drugs in different human genetic disorders including hereditary skin diseases. Our previous work revealed that aminoglycosides have effect on COL17A1 nonsense mutations and represent a therapeutic option to alleviate disease severity. However, the amount of restored type XVII collagen (C17) in C17 deficient junctional epidermolysis bullosa (JEB-C17) keratinocytes was less than 1% relative to normal keratinocytes and was achieved only after high dose gentamicin treatment, which induced deep transcriptional changes...
March 22, 2024: Journal of Investigative Dermatology
https://read.qxmd.com/read/38521922/adsorption-of-hg-2-cr-6-by-metal-binding-proteins-heterologously-expressed-in-escherichia-coli
#30
JOURNAL ARTICLE
Shuting Hu, Zixiang Wei, Teng Liu, Xinyu Zuo, Xiaoqiang Jia
BACKGROUND: Removal of heavy metals from water and soil is a pressing challenge in environmental engineering, and biosorption by microorganisms is considered as one of the most cost-effective methods. In this study, the metal-binding proteins MerR and ChrB derived from Cupriavidus metallidurans were separately expressed in Escherichia coli BL21 to construct adsorption strains. To improve the adsorption performance, surface display and codon optimization were carried out. RESULTS: In this study, we constructed 24 adsorption engineering strains for Hg2+ and Cr6+ , utilizing different strategies...
March 23, 2024: BMC Biotechnology
https://read.qxmd.com/read/38509572/modifications-of-the-5-region-of-the-caspon-tm-tag-s-mrna-further-enhance-soluble-recombinant-protein-production-in-escherichia-coli
#31
JOURNAL ARTICLE
Christoph Köppl, Wolfgang Buchinger, Gerald Striedner, Monika Cserjan-Puschmann
BACKGROUND: Escherichia coli is one of the most commonly used host organisms for the production of biopharmaceuticals, as it allows for cost-efficient and fast recombinant protein expression. However, challenging proteins are often produced with low titres or as inclusion bodies, and the manufacturing process needs to be developed individually for each protein. Recently, we developed the CASPONTM technology, a generic fusion tag-based platform process for high-titer soluble expression including a standardized downstream processing and highly specific enzymatic cleavage of the fusion tag...
March 20, 2024: Microbial Cell Factories
https://read.qxmd.com/read/38509174/enhancing-explainable-sars-cov-2-vaccine-development-leveraging-bee-colony-optimised-bi-lstm-bi-gru-models-and-bioinformatic-analysis
#32
JOURNAL ARTICLE
Dilber Uzun Ozsahin, Zubaida Said Ameen, Abdurrahman Shuaibu Hassan, Auwalu Saleh Mubarak
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA virus that caused the outbreak of the coronavirus disease 2019 (COVID-19). The COVID-19 outbreak has led to millions of deaths and economic losses globally. Vaccination is the most practical solution, but finding epitopes (antigenic peptide regions) in the SARS-CoV-2 proteome is challenging, costly, and time-consuming. Here, we proposed a deep learning method based on standalone Recurrent Neural networks to predict epitopes from SARS-CoV-2 proteins easily...
March 20, 2024: Scientific Reports
https://read.qxmd.com/read/38500114/new-improvements-in-grapevine-genome-editing-high-efficiency-biallelic-homozygous-knock-out-from-regenerated-plantlets-by-using-an-optimized-zcas9i
#33
JOURNAL ARTICLE
Jérémy Villette, Fatma Lecourieux, Eliot Bastiancig, Marie-Claire Héloir, Benoit Poinssot
BACKGROUND: For ten years, CRISPR/cas9 system has become a very useful tool for obtaining site-specific mutations on targeted genes in many plant organisms. This technology opens up a wide range of possibilities for improved plant breeding in the future. In plants, the CRISPR/Cas9 system is mostly used through stable transformation with constructs that allow for the expression of the Cas9 gene and sgRNA. Numerous studies have shown that site-specific mutation efficiency can vary greatly between different plant species due to factors such as plant transformation efficiency, Cas9 expression, Cas9 nucleotide sequence, the addition of intronic sequences, and many other parameters...
March 18, 2024: Plant Methods
https://read.qxmd.com/read/38498447/bioinformatic-analysis-of-codon-usage-bias-of-hsp20-genes-in-four-cruciferous-species
#34
JOURNAL ARTICLE
Huiyue Ji, Junnan Liu, Yineng Chen, Xinyi Yu, Chenlu Luo, Luxi Sang, Jiayu Zhou, Hai Liao
Heat shock protein 20 (HSP20) serves as a chaperone and plays roles in numerous biological processes, but the codon usage bias (CUB) of its genes has remained unexplored. This study identified 140 HSP20 genes from four cruciferous species, Arabidopsis thaliana , Brassica napus , Brassica rapa , and Camelina sativa , that were identified from the Ensembl plants database, and we subsequently investigated their CUB. As a result, the base composition analysis revealed that the overall GC content of HSP20 genes was below 50%...
February 6, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38492609/identification-of-an-n-terminal-tag-580n-that-improves-the-biosynthesis-of-fluorescent-proteins-in-francisella-tularensis-and-other-gram-negative-bacteria
#35
JOURNAL ARTICLE
Kristen Haggerty, Stuart Cantlay, Emily Young, Mariah K Cashbaugh, Elio F Delatore Iii, Rori Schreiber, Hayden Hess, Daniel R Komlosi, Sarah Butler, Dalton Bolon, Theresa Evangelista, Takoda Hager, Claire Kelly, Katherine Phillips, Jada Voellinger, Robert M Q Shanks, Joseph Horzempa
Utilization of fluorescent proteins is widespread for the study of microbial pathogenesis and host-pathogen interactions. Here, we discovered that linkage of the 36 N-terminal amino acids of FTL_0580 (a hypothetical protein of Francisella tularensis) to fluorescent proteins increases the fluorescence emission of bacteria that express these recombinant fusions. This N-terminal peptide will be referred to as 580N. Western blotting revealed that the linkage of 580N to Emerald Green Fluorescent Protein (EmGFP) in F...
March 14, 2024: Molecular and Cellular Probes
https://read.qxmd.com/read/38491213/cellular-energy-regulates-mrna-degradation-in-a-codon-specific-manner
#36
JOURNAL ARTICLE
Pedro Tomaz da Silva, Yujie Zhang, Evangelos Theodorakis, Laura D Martens, Vicente A Yépez, Vicent Pelechano, Julien Gagneur
Codon optimality is a major determinant of mRNA translation and degradation rates. However, whether and through which mechanisms its effects are regulated remains poorly understood. Here we show that codon optimality associates with up to 2-fold change in mRNA stability variations between human tissues, and that its effect is attenuated in tissues with high energy metabolism and amplifies with age. Mathematical modeling and perturbation data through oxygen deprivation and ATP synthesis inhibition reveal that cellular energy variations non-uniformly alter the effect of codon usage...
March 15, 2024: Molecular Systems Biology
https://read.qxmd.com/read/38488603/whole-proteome-screening-to-develop-a-potent-epitope-based-vaccine-against-coxiella-burnetii-a-reverse-vaccinology-approach
#37
JOURNAL ARTICLE
Ali Forouharmehr
Coxiellosis is known as a threat to human health. This study aimed to develop an epitope-based vaccine against coxiellosis using a whole proteome investigation. In this case, the whole proteome of Coxiella burnetii was collected from the database, then different assessments were performed to select immunogenic proteins. The selected proteins were used for epitopes prediction. The epitope-based vaccine was made using the best-selected epitopes and HBHA protein. The physical and chemical features, as well as secondary and tertiary structures of the developed vaccine were analyzed...
March 15, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38486475/a-novel-immunoinformatics-approach-for-developing-a-poly-epitope-vaccine-targeting-foot-and-mouth-disease-virus-exploiting-structural-vp-proteins
#38
JOURNAL ARTICLE
Muhammad Saad Bhutta, Muhammad Awais, Sahar Sadaqat, Fernando Berton Zanchi, Naila Shahid, Abdul Qayyum Rao
Foot and mouth Disease virus (FMDV) belongs to Picornaviridae family and Aphthovirus genus causing Foot and mouth disease (FMD) in cloven-hoofed animals. FMDV, a prevalent virus induces both acute and chronic infections with high mutation rates resulting in seven primary serotypes, making vaccine development indispensable. Due to time and cost effectiveness of the immunoinformatic approach, we designed in-silico polyepitope vaccine (PEV) for the curtailment of FMDV. Structural and immunogenic parts of FMDV (Viral Protein 1 (VP1), Viral Protein 2 (VP2), Viral Protein 3 (VP3), and Viral Protein 4 (VP4)) were used to design the cytotoxic T Lymphocyte (CTL), Helper T Lymphocyte (HTL), and B-cell epitopes, followed by screening for antigenic, non-allergenic, Interferon (IFN) simulator, and non-toxicity, which narrowed down to 7 CTL, 3 HTL, and 12 B-cell epitopes...
March 15, 2024: Journal of Biomolecular Structure & Dynamics
https://read.qxmd.com/read/38481819/hypoxia-activated-selectivity-improved-anti-pkm2-antibody-combined-with-prodrug-th-302-for-potentiated-targeting-therapy-in-hepatocellular-carcinoma
#39
JOURNAL ARTICLE
Bo Wang, Fang-Zheng Qi, Ping Chen, Luo-Meng Qian, Hui-Shan Su, Yang Wang, Chen-Hui Wang, Ya-Xin Hou, Qing Zhang, Ding Li, Zhe-Sheng Chen, Si-He Zhang
Background: Hypoxia induces hepatocellular carcinoma (HCC) malignancies; yet it also offers treatment opportunities, exemplified by developing hypoxia-activated prodrugs (HAPs). Although HAP TH-302 combined with therapeutic antibody (Ab) has synergistic effects, the clinical benefits are limited by the on-target off-tumor toxicity of Ab. Here, we sought to develop a hypoxia-activated anti-M2 splice isoform of pyruvate kinase (PKM2) Ab combined with TH-302 for potentiated targeting therapy. Methods: Codon-optimized and hypoxia-activation strategies were used to develop H103 Ab-azo-PEG5k (HAP103) Ab...
2024: International Journal of Biological Sciences
https://read.qxmd.com/read/38480976/adeno-associated-virus-mediated-trastuzumab-delivery-to-the-central-nervous-system-for-human-epidermal-growth-factor-receptor-2-brain-metastasis
#40
JOURNAL ARTICLE
Marcela S Werner, Shweta Aras, Ashleigh R Morgan, Jillian Roamer, Nesteene J Param, Kanyin Olagbegi, R Jason Lamontagne, Jenny A Greig, James M Wilson
Trastuzumab improves overall survival for HER2+ breast cancer, but its short half-life in the cerebrospinal fluid (~2-4 days) and delivery limitations restrict the ability to target HER2+ central nervous system (CNS) disease. We developed an adeno-associated virus (AAV) vector expressing a codon-optimized, ubiquitin C (UbC)-promoter-driven trastuzumab sequence (AAV9.UbC.trastuzumab) for intrathecal administration. Transgene expression was evaluated in adult Rag1 knockout mice and rhesus nonhuman primates (NHPs) after a single intracerebroventricular (ICV) or intra-cisterna magna (ICM) AAV9...
March 13, 2024: Cancer Gene Therapy
keyword
keyword
52405
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.